PMA SELECTS Ex-PFIZER LOBBYIST CONAFAY FOR NEW EXEC VP POSITION; POLITICAL CHOICE ON TWO LEVELS: BUILDING BRIDGES WITHIN PMA AS WELL AS ON CAPITOL HILL
Pharmaceutical Manufacturers Association Exec VP-Strategic Affairs Stephen Conafay, 50, comes to the position with an established track record in Washington lobbying on issues affecting the pharmaceutical industry, a network of long-term relationships with the senior exec group in the industry, and the potential for fitting into the existing association management structure.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth